![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » MALVERN FIRM EXPANDING CAPABILITIES
MALVERN FIRM EXPANDING CAPABILITIES
Fujirebio Diagnostics said it acquired 100 percent of the stock and equity of CanAg Diagnostics AB, a Swedish biotechnology company based in Gothenburg, Sweden. Takeo Hayashi, Fujirebio chairman and chief executive, said the acquisition will expand the company's capabilities in cancer diagnostics and give Fujirebio a bigger worldwide presence. Financial terms were not disclosed.
Daily Local News Online
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct